Labshake search
Citations for Bio X Cell :
1 - 50 of 913 citations for Pituitary Tumor Transforming 1 PTTG1 Antibody since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... Tumors were treated with anti-PD-1 purchased from BioxCell InVivoMAb anti-mouse PD-1 (catalog #BE0146) ...
-
bioRxiv - Cell Biology 2020Quote: ... mice bearing ~50mm3 tumors were randomized and treated with 200 μg of anti-PD-1 antibody (BioXcell, Clone RMP1-14) or isotype control via IP injections three times weekly for 4 doses ...
-
bioRxiv - Immunology 2020Quote: Tumor and draining lymph node samples were blocked with anti-mouse CD16/32 antibodies (BioXCell) for 20 min at 4 °C and stained with surface antibodies (Supplementary Table 1 ...
-
bioRxiv - Cancer Biology 2020Quote: ... tumor-bearing mice were intraperitoneally injected (8-10mg/kg) with either an IgG2a isotype control antibody (BioXCell #BE0089), or an anti-PD-1 antibody (BioXCell #BE0146 ...
-
bioRxiv - Immunology 2021Quote: ... B16-OVA tumor bearing mice were treated with 200 µg of anti-CD8α monoclonal antibody (clone 53-6.7, BioXcell) or 200 µg of anti-NK1.1 monoclonal antibody (clone PK136 ...
-
bioRxiv - Neuroscience 2024Quote: ... MMTV-PyMT +/- female mice at 7 weeks after the tumor onset were intravenously injected with the anti-PD-L1 antibody (BioXcell, #BE0101 ...
-
bioRxiv - Immunology 2023Quote: ... Tumor-bearing mice were treated with anti-CTLA-4 (BioXCell) (n=8 ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 13 after orthotopic tumor implantatio n mice were intraperitoneally injected with 200 μg of anti-PD-L1 monoclonal antibody (RMP1-14, BioXCell, BE0146, Lot: 810421D1) or isotype control (IgG2a ...
-
bioRxiv - Cancer Biology 2022Quote: ... αPD-1 antibody (BioXCell, Clone #BE0273 ...
-
bioRxiv - Cancer Biology 2021Quote: For checkpoint blockade treatment optimization on mc38 tumors anti-PD1 (RMP1-14, Bioxcell), anti-PD1 (mPD1-4H2-mIgG1-D265A ...
-
bioRxiv - Cancer Biology 2021Quote: ... C26 tumor-bearing mice received intraperitoneal injections with InVivoMAb anti-mouse IL-6 (1 mg in 200μl PBS; Bio X Cell, clone MP5-20F3). Body weight ...
-
bioRxiv - Immunology 2019Quote: ... 4T1 tumor-bearing mice were injected intraperitoneally with 250 μg anti-PD1 (InVivoPlus RMP1-14, BioXCell) and/or 100μg anti-CTLA4 antibodies (InVivoPlus 9H10 ...
-
bioRxiv - Immunology 2022Quote: ... or were completely clear of tumors: anti-CD8-α for CD8+ T cells (clone 2.43, BioXCell), anti-CD4 for CD4+ T cells (clone GK1.5 ...
-
bioRxiv - Immunology 2023Quote: ... or were completely clear of tumors: anti-CD8-α for CD8+ T cells (clone 2.43, BioXCell), anti-CD4 for CD4+ T cells (clone GK1.5 ...
-
bioRxiv - Cancer Biology 2019Quote: ... or an anti-PD-1 antibody (BioXCell) at a dose of 200 Antibodies ...
-
bioRxiv - Cancer Biology 2024Quote: ... anti-PD-1 antibody (BioXcell cat.# BE0146) at 100ug per mouse every 3 days ...
-
bioRxiv - Cancer Biology 2023Quote: ... Antibodies used were rat anti-mouse PD-1 IgG2a antibody (RMP1-14, BioXCell), rat anti-CD40 agonist IgG2a antibody (FGK4.5 ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... The anti-PD-1 monoclonal antibody αPD-1 (Clone RMP1-14, Bioxcell) was administered at 10 mg/kg ...
-
bioRxiv - Cancer Biology 2020Quote: ... or an anti-PD-1 antibody (BioXCell #BE0146) twice weekly starting 7-10 days after injection of cancer cells.
-
bioRxiv - Cancer Biology 2019Quote: ... and αPD-1 antibody (Clone: RMP1-14, BioXcell) were diluted in sterile PBS and delivered through intraperitoneal injections at a dose of 10mg/kg.
-
bioRxiv - Neuroscience 2023Quote: ... anti-mouse Ly-6G antibody (BioxCell, BE0075-1), anti-mouse IL-6 antibody (BioXCell ...
-
bioRxiv - Cancer Biology 2023Quote: ... The anti–PD-1 antibody RMP1-14 (BioXCell) was administered i.p ...
-
bioRxiv - Immunology 2024Quote: ... Anti-PD-1 antibody (clone RMP1-14, BioXcell) was injected intraperitoneally in the corresponding groups at day 6 and day 18 after tumor cell inoculation ...
-
bioRxiv - Immunology 2023Quote: ... Anti-PD-1 antibody (Clone: J43) or IgG antibody (200 μg/mouse, Bio X Cell) was intraperitoneally administered every 3 days from 10 days after the inoculation of Hepa 1-6 cells ...
-
bioRxiv - Cancer Biology 2020Quote: ... α-PD-1 antibody (200 μg; RMP1-14, BioXcell) was used ...
-
bioRxiv - Immunology 2021Quote: 300μg anti-mouse PD-1 antibody (clone J43, BioXcell) was administered intraperitoneal (IP ...
-
bioRxiv - Immunology 2021Quote: ... and anti-CD40 antibody (BioXcell, BE0189, 1 μg/ml]), or Fluzone (BEI resources ...
-
bioRxiv - Immunology 2023Quote: ... plus anti-CD28 antibodies (1μg/ml, PV-1, BioXcell) and incubated at 37°C with 5% CO2 for 48 hours ...
-
bioRxiv - Immunology 2023Quote: ... 1 mg of W6/32 antibody (BioXCell, Cat #BE0079) was coupled to sepharose in the presence of binding buffer (150mM sodium chloride ...
-
bioRxiv - Cancer Biology 2023Quote: ... 1 mg of W6/32 antibody (Bio X Cell) were coupled to Sepharose in the presence of binding buffer (150 mM sodium chloride ...
-
bioRxiv - Immunology 2023Quote: ... tumor-bearing mice were injected intraperitoneally with 100 μg of anti-CTLA-4 (clone UC10-4F10-11, Bio X Cell) and 100 μg of anti-PD-L1 (clone 10F.9G2 ...
-
bioRxiv - Cancer Biology 2024Quote: Tumor-bearing mice were injected intraperitoneally every four days with either cocktail of anti-PD1 (250 μg/dose, #BE0146, BioXcell) and anti-CTLA4 (100 μg/dose ...
-
bioRxiv - Cancer Biology 2023Quote: ... we injected mice (i.p.) bearing MC38 tumors with 200 μg mouse IgG1 isotype control (clone MOPC-21; BioXCell; Cat #EB0083) or 200 μg mouse αIFNAR1 antibody (clone MAR1-5A3 ...
-
PD-1 checkpoint blockade disrupts CD4 T cell regulated adaptive B cell tolerance to foreign antigensbioRxiv - Immunology 2021Quote: ... or anti-PD-1 antibody clone J43 (BioXcell; NP-J43). Immunizations were performed by subcutaneous (sc ...
-
bioRxiv - Immunology 2021Quote: ... and CD4 depleting antibody (clone GK1.5, BioXCell, cat. BP0003-1) were administered either in combination or as single agents at 200ug/antibody/mouse every third day starting one week prior to doxycycline diet addition for seven total doses.
-
bioRxiv - Immunology 2021Quote: ... PD-1 blocking antibody (clone 29F.1A12, BioXCell, cat. BP0273) and CTLA-4 blocking antibody (clone 9D9 ...
-
bioRxiv - Immunology 2021Quote: ... CD8 depleting antibody (clone 53-6.7, BioXCell, cat. BP0004-1) and CD4 depleting antibody (clone GK1.5 ...
-
bioRxiv - Cancer Biology 2023Quote: ... monoclonal antibodies against murine PD-1 were purchased from BioXcell and given as intraperitoneal loading dose on first day of administration and every 3-4 d thereafter to wildtype C57Bl/6 mice bearing intracranial cortical GL261 or K-luc tumors.
-
bioRxiv - Cancer Biology 2023Quote: ... anti-mouse PD-1 antibody (BioXCell, clone RMP1-14, BE0146), anti-mouse PD-L1 antibody (BioXCell ...
-
bioRxiv - Bioengineering 2023Quote: ... or its IgG2c isotype control antibody (BioXcell, clone DV5-1). Two days later ...
-
bioRxiv - Immunology 2023Quote: ... 400 μg CD4 depletion antibody (Clone GK1.5, BioXCell, BE0003-1) in 200 μl PBS was injected intraperitoneally at day −2 and day −1 prior to tumor inoculation ...
-
bioRxiv - Cancer Biology 2023Quote: ... injected with an αIFNAR-1 antibody (200 μg; MAR15A3, BioXcell) twice per week ...
-
bioRxiv - Immunology 2024Quote: ... or 10mg/kg anti-PD-1 antibody (BioXCell; cat#:BE0146) IP ...
-
bioRxiv - Cancer Biology 2020Quote: ... were used for checkpoint blocking on tumors as well as T cells: functional grade PD-L1 (29E.2A3) and CTLA-4 (BN13) (Bioxcell, USA). In brief ...
-
bioRxiv - Immunology 2020Quote: Murine neutrophils were depleted with mLy6G (Gr-1) antibody (BioXcell; BE0075) intraperitoneally every 5-7 days as described before 28.
-
bioRxiv - Immunology 2022Quote: ... Anti-mouse PD-1 (RMP1-14) antibody was purchased from BioXcell.
-
bioRxiv - Immunology 2023Quote: CD4-specific antibody (clone YTS191; cat. #BE0003-1; Bio X Cell) and CD8a-specific antibody (clone YTS169.4 ...
-
bioRxiv - Immunology 2023Quote: ... 1 ug/mL of agonistic anti-CD40 antibody (Clone FGK4.5, BioXCell) diluted in PBS was added to all wells ...
-
bioRxiv - Immunology 2024Quote: ... IFN-I receptor subunit 1 (IFNAR1) blocking antibody (MAR1-5A3) and IgG isotype control antibody (MOPC-21) from BioXCell. S ...
-
bioRxiv - Cancer Biology 2020Quote: ... with 200 μg of ◻PD-L1 (10F.9G2) or αPD-1 (RMP1-14) or αCTLA-4 (9H10) antibody or with isotype control antibodies (all from BioXcell) on days 9 ...